Filing Details

Accession Number:
0001209191-17-049546
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-08-17 20:36:39
Reporting Period:
2017-08-16
Filing Date:
2017-08-17
Accepted Time:
2017-08-17 20:36:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1438533 Retrophin Inc. RTRX Pharmaceutical Preparations (2834) 262383102
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1681098 F. Neil Mcfarlane C/O Retrophin, Inc.
3721 Valley Centre Dr., Suite 200
San Diego CA 92130
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-08-16 1,378 $22.50 13,622 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Shares were sold to cover the tax obligation that occurred upon the vesting of an RSU.